What do we do?
One of our time's serious health and economic problems is the increasing ageing of the population in
developed societies. Increased longevity is associated with the risk of many diseases of old age (muscular
degeneration, diabetes, neurodegenerative diseases, cancer, etc.). We must invest more and more energy and
resources in the symptomatic treatment of neurodegenerative diseases, which are still incurable. Therefore,
research of a kind that contributes to the number of active and healthy years over an extended life span is
not only of holistic but also social and economic importance. The main goal of our research group is to
discover new regulatory points to improve the quality of life in old age and prevent the onset of many
neurodegenerative diseases. For ageing, the survival of nerve cells is essential, as these cells cannot
divide and, if they die, tissue regeneration is not possible. Autophagy is a cell-protective degradative
process in which cells eliminate their harmful components, while gaining essential components for energy and
anabolic processes. Through this degradation, the cell can also eliminate toxic molecules (e.g. damaged,
malfunctioning mitochondria, mutant Huntingtin, α-synuclein proteins, etc.) that are involved in
neurodegenerative diseases. Currently available autophagy activators are not specific enough and can cause a
number of adverse side effects. We expect our findings to identify new regulatory points that can be used to
specifically activate autophagy degradation steps that promote cell survival. These new regulatory points
could be used to design drug candidates to prevent the progression of dementia or neurodegenerative diseases
in later life.
What tools we use for research?
Drosophila melanogaster is one of the best-known model organisms, and
research and research on it can easily and rapidly yield results that can be conserved throughout the
eukaryotes. Drosophila genome contains the ortholoques of more than 70% of the genes that cause human
diseases, and is one of the best researched model organisms in autophagy. Drosophila is also an
excellent candidate for research of ageing and neurodegeneration, due to its short lifespan and the fact
that its nervous system is composed of neurons (many neurotransmitters are identical) and glia cells similar
to humans. In our experiments, our research group uses a combination of classical genetic, cell imaging and
molecular tools. Our research involves the investigation of several neurodegenerative models (Parkinson's
disease, Huntington's disease, SCA1) from a pharmacological and genetic point of view.